Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity

The non-classical class Ib molecule human leukocyte antigen E (HLA-E) has limited polymorphism and can bind HLA class Ia leader peptides (VL9). HLA-E-VL9 complexes interact with the natural killer (NK) cell receptors NKG2A-C/CD94 and regulate NK cell-mediated cytotoxicity. Here we report the isolati...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Communications biology Ročník 5; číslo 1; s. 271 - 17
Hlavní autori: Li, Dapeng, Brackenridge, Simon, Walters, Lucy C., Swanson, Olivia, Harlos, Karl, Rozbesky, Daniel, Cain, Derek W., Wiehe, Kevin, Scearce, Richard M., Barr, Maggie, Mu, Zekun, Parks, Robert, Quastel, Max, Edwards, Robert J., Wang, Yunfei, Rountree, Wes, Saunders, Kevin O., Ferrari, Guido, Borrow, Persephone, Jones, E. Yvonne, Alam, S. Munir, Azoitei, Mihai L., Gillespie, Geraldine M., McMichael, Andrew J., Haynes, Barton F.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: London Nature Publishing Group UK 28.03.2022
Nature Publishing Group
Nature Portfolio
Predmet:
13/1
13/106
13/109
13/31
14/28
14/34
14/63
38
38/77
42
631/250/1619/382
631/250/2152/2153/1291
631/535/1266
631/61/51/1568
64/60
82
82/80
82/83
Animals
Antibodies
Biology
Biomedical and Life Sciences
Cytomegalovirus
Cytotoxicity
Cytotoxicity, Immunologic
Histocompatibility antigen HLA
Histocompatibility Antigens Class I - genetics
HLA Antigens
HLA-E Antigens
Humans
Immunoglobulin G
Immunoglobulin M
Immunoglobulins - metabolism
Killer Cells, Natural
Life Sciences
Lymphocytes B
Mice
Natural killer cells
NKG2 antigen
Peptides - metabolism
Protein Sorting Signals
ISSN:2399-3642, 2399-3642
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract The non-classical class Ib molecule human leukocyte antigen E (HLA-E) has limited polymorphism and can bind HLA class Ia leader peptides (VL9). HLA-E-VL9 complexes interact with the natural killer (NK) cell receptors NKG2A-C/CD94 and regulate NK cell-mediated cytotoxicity. Here we report the isolation of 3H4, a murine HLA-E-VL9-specific IgM antibody that enhances killing of HLA-E-VL9-expressing cells by an NKG2A + NK cell line. Structural analysis reveal that 3H4 acts by preventing CD94/NKG2A docking on HLA-E-VL9. Upon in vitro maturation, an affinity-optimized IgG form of 3H4 showes enhanced NK killing of HLA-E-VL9-expressing cells. HLA-E-VL9-specific IgM antibodies similar in function to 3H4 are also isolated from naïve B cells of cytomegalovirus (CMV)-negative, healthy humans. Thus, HLA-E-VL9-targeting mouse and human antibodies isolated from the naïve B cell antibody pool have the capacity to enhance NK cell cytotoxicity. The identification and structural analysis of HLA-E-VL9-targeting antibodies that block a natural killer (NK) cell receptor pathway and regulate NK function in vitro.
AbstractList The non-classical class Ib molecule human leukocyte antigen E (HLA-E) has limited polymorphism and can bind HLA class Ia leader peptides (VL9). HLA-E-VL9 complexes interact with the natural killer (NK) cell receptors NKG2A-C/CD94 and regulate NK cell-mediated cytotoxicity. Here we report the isolation of 3H4, a murine HLA-E-VL9-specific IgM antibody that enhances killing of HLA-E-VL9-expressing cells by an NKG2A NK cell line. Structural analysis reveal that 3H4 acts by preventing CD94/NKG2A docking on HLA-E-VL9. Upon in vitro maturation, an affinity-optimized IgG form of 3H4 showes enhanced NK killing of HLA-E-VL9-expressing cells. HLA-E-VL9-specific IgM antibodies similar in function to 3H4 are also isolated from naïve B cells of cytomegalovirus (CMV)-negative, healthy humans. Thus, HLA-E-VL9-targeting mouse and human antibodies isolated from the naïve B cell antibody pool have the capacity to enhance NK cell cytotoxicity.
The identification and structural analysis of HLA-E-VL9-targeting antibodies that block a natural killer (NK) cell receptor pathway and regulate NK function in vitro.
The non-classical class Ib molecule human leukocyte antigen E (HLA-E) has limited polymorphism and can bind HLA class Ia leader peptides (VL9). HLA-E-VL9 complexes interact with the natural killer (NK) cell receptors NKG2A-C/CD94 and regulate NK cell-mediated cytotoxicity. Here we report the isolation of 3H4, a murine HLA-E-VL9-specific IgM antibody that enhances killing of HLA-E-VL9-expressing cells by an NKG2A+ NK cell line. Structural analysis reveal that 3H4 acts by preventing CD94/NKG2A docking on HLA-E-VL9. Upon in vitro maturation, an affinity-optimized IgG form of 3H4 showes enhanced NK killing of HLA-E-VL9-expressing cells. HLA-E-VL9-specific IgM antibodies similar in function to 3H4 are also isolated from naïve B cells of cytomegalovirus (CMV)-negative, healthy humans. Thus, HLA-E-VL9-targeting mouse and human antibodies isolated from the naïve B cell antibody pool have the capacity to enhance NK cell cytotoxicity.The non-classical class Ib molecule human leukocyte antigen E (HLA-E) has limited polymorphism and can bind HLA class Ia leader peptides (VL9). HLA-E-VL9 complexes interact with the natural killer (NK) cell receptors NKG2A-C/CD94 and regulate NK cell-mediated cytotoxicity. Here we report the isolation of 3H4, a murine HLA-E-VL9-specific IgM antibody that enhances killing of HLA-E-VL9-expressing cells by an NKG2A+ NK cell line. Structural analysis reveal that 3H4 acts by preventing CD94/NKG2A docking on HLA-E-VL9. Upon in vitro maturation, an affinity-optimized IgG form of 3H4 showes enhanced NK killing of HLA-E-VL9-expressing cells. HLA-E-VL9-specific IgM antibodies similar in function to 3H4 are also isolated from naïve B cells of cytomegalovirus (CMV)-negative, healthy humans. Thus, HLA-E-VL9-targeting mouse and human antibodies isolated from the naïve B cell antibody pool have the capacity to enhance NK cell cytotoxicity.
The non-classical class Ib molecule human leukocyte antigen E (HLA-E) has limited polymorphism and can bind HLA class Ia leader peptides (VL9). HLA-E-VL9 complexes interact with the natural killer (NK) cell receptors NKG2A-C/CD94 and regulate NK cell-mediated cytotoxicity. Here we report the isolation of 3H4, a murine HLA-E-VL9-specific IgM antibody that enhances killing of HLA-E-VL9-expressing cells by an NKG2A+ NK cell line. Structural analysis reveal that 3H4 acts by preventing CD94/NKG2A docking on HLA-E-VL9. Upon in vitro maturation, an affinity-optimized IgG form of 3H4 showes enhanced NK killing of HLA-E-VL9-expressing cells. HLA-E-VL9-specific IgM antibodies similar in function to 3H4 are also isolated from naïve B cells of cytomegalovirus (CMV)-negative, healthy humans. Thus, HLA-E-VL9-targeting mouse and human antibodies isolated from the naïve B cell antibody pool have the capacity to enhance NK cell cytotoxicity.The identification and structural analysis of HLA-E-VL9-targeting antibodies that block a natural killer (NK) cell receptor pathway and regulate NK function in vitro.
The non-classical class Ib molecule human leukocyte antigen E (HLA-E) has limited polymorphism and can bind HLA class Ia leader peptides (VL9). HLA-E-VL9 complexes interact with the natural killer (NK) cell receptors NKG2A-C/CD94 and regulate NK cell-mediated cytotoxicity. Here we report the isolation of 3H4, a murine HLA-E-VL9-specific IgM antibody that enhances killing of HLA-E-VL9-expressing cells by an NKG2A + NK cell line. Structural analysis reveal that 3H4 acts by preventing CD94/NKG2A docking on HLA-E-VL9. Upon in vitro maturation, an affinity-optimized IgG form of 3H4 showes enhanced NK killing of HLA-E-VL9-expressing cells. HLA-E-VL9-specific IgM antibodies similar in function to 3H4 are also isolated from naïve B cells of cytomegalovirus (CMV)-negative, healthy humans. Thus, HLA-E-VL9-targeting mouse and human antibodies isolated from the naïve B cell antibody pool have the capacity to enhance NK cell cytotoxicity. The identification and structural analysis of HLA-E-VL9-targeting antibodies that block a natural killer (NK) cell receptor pathway and regulate NK function in vitro.
The non-classical class Ib molecule human leukocyte antigen E (HLA-E) has limited polymorphism and can bind HLA class Ia leader peptides (VL9). HLA-E-VL9 complexes interact with the natural killer (NK) cell receptors NKG2A-C/CD94 and regulate NK cell-mediated cytotoxicity. Here we report the isolation of 3H4, a murine HLA-E-VL9-specific IgM antibody that enhances killing of HLA-E-VL9-expressing cells by an NKG2A + NK cell line. Structural analysis reveal that 3H4 acts by preventing CD94/NKG2A docking on HLA-E-VL9. Upon in vitro maturation, an affinity-optimized IgG form of 3H4 showes enhanced NK killing of HLA-E-VL9-expressing cells. HLA-E-VL9-specific IgM antibodies similar in function to 3H4 are also isolated from naïve B cells of cytomegalovirus (CMV)-negative, healthy humans. Thus, HLA-E-VL9-targeting mouse and human antibodies isolated from the naïve B cell antibody pool have the capacity to enhance NK cell cytotoxicity.
ArticleNumber 271
Author McMichael, Andrew J.
Parks, Robert
Saunders, Kevin O.
Ferrari, Guido
Jones, E. Yvonne
Barr, Maggie
Brackenridge, Simon
Scearce, Richard M.
Mu, Zekun
Swanson, Olivia
Cain, Derek W.
Walters, Lucy C.
Harlos, Karl
Gillespie, Geraldine M.
Azoitei, Mihai L.
Borrow, Persephone
Li, Dapeng
Wang, Yunfei
Edwards, Robert J.
Alam, S. Munir
Rozbesky, Daniel
Wiehe, Kevin
Quastel, Max
Rountree, Wes
Haynes, Barton F.
Author_xml – sequence: 1
  givenname: Dapeng
  orcidid: 0000-0002-8131-5914
  surname: Li
  fullname: Li, Dapeng
  organization: Duke Human Vaccine Institute, Duke University School of Medicine, Department of Medicine, Duke University School of Medicine
– sequence: 2
  givenname: Simon
  orcidid: 0000-0002-0587-7560
  surname: Brackenridge
  fullname: Brackenridge, Simon
  organization: Nuffield Department of Clinical Medicine, University of Oxford
– sequence: 3
  givenname: Lucy C.
  surname: Walters
  fullname: Walters, Lucy C.
  organization: Nuffield Department of Clinical Medicine, University of Oxford
– sequence: 4
  givenname: Olivia
  orcidid: 0000-0001-8162-8358
  surname: Swanson
  fullname: Swanson, Olivia
  organization: Duke Human Vaccine Institute, Duke University School of Medicine
– sequence: 5
  givenname: Karl
  orcidid: 0000-0002-7266-4354
  surname: Harlos
  fullname: Harlos, Karl
  organization: Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford
– sequence: 6
  givenname: Daniel
  surname: Rozbesky
  fullname: Rozbesky, Daniel
  organization: Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Department of Cell Biology, Charles University
– sequence: 7
  givenname: Derek W.
  surname: Cain
  fullname: Cain, Derek W.
  organization: Duke Human Vaccine Institute, Duke University School of Medicine, Department of Medicine, Duke University School of Medicine
– sequence: 8
  givenname: Kevin
  surname: Wiehe
  fullname: Wiehe, Kevin
  organization: Duke Human Vaccine Institute, Duke University School of Medicine, Department of Medicine, Duke University School of Medicine
– sequence: 9
  givenname: Richard M.
  surname: Scearce
  fullname: Scearce, Richard M.
  organization: Duke Human Vaccine Institute, Duke University School of Medicine
– sequence: 10
  givenname: Maggie
  surname: Barr
  fullname: Barr, Maggie
  organization: Duke Human Vaccine Institute, Duke University School of Medicine
– sequence: 11
  givenname: Zekun
  orcidid: 0000-0003-4093-8346
  surname: Mu
  fullname: Mu, Zekun
  organization: Duke Human Vaccine Institute, Duke University School of Medicine
– sequence: 12
  givenname: Robert
  surname: Parks
  fullname: Parks, Robert
  organization: Duke Human Vaccine Institute, Duke University School of Medicine
– sequence: 13
  givenname: Max
  orcidid: 0000-0001-6551-4713
  surname: Quastel
  fullname: Quastel, Max
  organization: Nuffield Department of Clinical Medicine, University of Oxford
– sequence: 14
  givenname: Robert J.
  orcidid: 0000-0003-4446-1194
  surname: Edwards
  fullname: Edwards, Robert J.
  organization: Duke Human Vaccine Institute, Duke University School of Medicine, Department of Medicine, Duke University School of Medicine
– sequence: 15
  givenname: Yunfei
  surname: Wang
  fullname: Wang, Yunfei
  organization: Duke Human Vaccine Institute, Duke University School of Medicine, Department of Medicine, Duke University School of Medicine
– sequence: 16
  givenname: Wes
  surname: Rountree
  fullname: Rountree, Wes
  organization: Duke Human Vaccine Institute, Duke University School of Medicine, Department of Medicine, Duke University School of Medicine
– sequence: 17
  givenname: Kevin O.
  orcidid: 0000-0001-7399-7954
  surname: Saunders
  fullname: Saunders, Kevin O.
  organization: Duke Human Vaccine Institute, Duke University School of Medicine, Department of Immunology, Duke University School of Medicine, Department of Surgery, Duke University School of Medicine
– sequence: 18
  givenname: Guido
  surname: Ferrari
  fullname: Ferrari, Guido
  organization: Department of Surgery, Duke University School of Medicine
– sequence: 19
  givenname: Persephone
  orcidid: 0000-0002-3877-9780
  surname: Borrow
  fullname: Borrow, Persephone
  organization: Nuffield Department of Clinical Medicine, University of Oxford
– sequence: 20
  givenname: E. Yvonne
  orcidid: 0000-0002-3834-1893
  surname: Jones
  fullname: Jones, E. Yvonne
  organization: Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford
– sequence: 21
  givenname: S. Munir
  surname: Alam
  fullname: Alam, S. Munir
  organization: Duke Human Vaccine Institute, Duke University School of Medicine, Department of Medicine, Duke University School of Medicine
– sequence: 22
  givenname: Mihai L.
  orcidid: 0000-0002-4080-1350
  surname: Azoitei
  fullname: Azoitei, Mihai L.
  email: mihai.azoitei@duke.edu
  organization: Duke Human Vaccine Institute, Duke University School of Medicine, Department of Medicine, Duke University School of Medicine
– sequence: 23
  givenname: Geraldine M.
  orcidid: 0000-0002-1075-870X
  surname: Gillespie
  fullname: Gillespie, Geraldine M.
  email: geraldine.gillespie@ndm.ox.ac.uk
  organization: Nuffield Department of Clinical Medicine, University of Oxford
– sequence: 24
  givenname: Andrew J.
  orcidid: 0000-0002-9101-7478
  surname: McMichael
  fullname: McMichael, Andrew J.
  email: andrew.mcmichael@ndm.ox.ac.uk
  organization: Nuffield Department of Clinical Medicine, University of Oxford
– sequence: 25
  givenname: Barton F.
  orcidid: 0000-0002-7643-9023
  surname: Haynes
  fullname: Haynes, Barton F.
  email: barton.haynes@duke.edu
  organization: Duke Human Vaccine Institute, Duke University School of Medicine, Department of Immunology, Duke University School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35347236$$D View this record in MEDLINE/PubMed
BookMark eNp9ks1uEzEUhUeoiJbSF2CBRmLDZsD2tWfGG6SqKrQiwAbWln_uJI4mdrAnVfP2OEkLbRdd-co-59PV8XldHYUYsKreUvKREug_Zc4IgYYw1hCgPTTiRXXCQMoGWs6OHszH1VnOS0IIlVK2wF9VxyCAdwzak0p9j5uMtQ6uXmxWOpRp8iY6j7k2vtxezc6by2ZE7TDVa1xP3mFt42o94m3R7IwYFjpYrH98qy2OY223U5zirbd-2r6pXg56zHh2d55Wv79c_rq4amY_v15fnM8aKziZGq6BIgFLezpA54x0phdGWwEdtFQOzAnZdRqgRdJaGLBzoI0hgzCyHaiG0-r6wHVRL9U6-ZVOWxW1V_uLmOZKp8nbERUR0gygC9Jx3pHWaKaJJg6J4RJZW1ifD6z1xqzQWQxT0uMj6OOX4BdqHm9UL1vSSVoAH-4AKf7ZYJ7UyuddNDpgiVuxlnMJPRFdkb5_Il3GTQolqr2KgejJDvju4Ub_Vrn_xyLoDwKbYs4JB1XC15OPuwX9qChRu9aoQ2tUaY3at0aJYmVPrPf0Z01wMOUiDnNM_9d-xvUXGJnTrg
CitedBy_id crossref_primary_10_3389_fimmu_2023_1217809
crossref_primary_10_1016_j_beha_2024_101568
crossref_primary_10_1016_j_bioactmat_2023_08_001
crossref_primary_10_3389_fimmu_2022_960852
crossref_primary_10_1016_j_drudis_2022_103436
crossref_primary_10_3389_fimmu_2022_1080596
crossref_primary_10_3390_ijms26189009
crossref_primary_10_3389_fimmu_2025_1546939
crossref_primary_10_1186_s40824_023_00404_8
crossref_primary_10_3390_cancers15041264
crossref_primary_10_3389_fimmu_2023_1289212
crossref_primary_10_1111_imr_13434
crossref_primary_10_1007_s00432_022_04532_x
crossref_primary_10_1093_immadv_ltaf029
Cites_doi 10.1016/j.molimm.2009.10.024
10.1016/S1097-2765(00)80053-2
10.1371/journal.pone.0135972
10.1002/(SICI)1521-4141(199904)29:04<1076::AID-IMMU1076>3.0.CO;2-Z
10.1371/journal.ppat.1000782
10.1093/intimm/dxn141
10.1084/jem.20110363
10.1107/S0907444912001308
10.1128/JVI.03309-13
10.1016/j.jmb.2007.05.022
10.1097/00007890-200002150-00001
10.1186/s40425-019-0761-3
10.1038/nm.3743
10.1016/j.smim.2006.03.003
10.1084/jem.162.6.1745
10.1155/2014/352160
10.1073/pnas.1525510113
10.4049/jimmunol.168.7.3145
10.1016/j.molimm.2012.07.009
10.1097/TP.0b013e318186d87b
10.1107/S0907444904026460
10.3389/fimmu.2016.00091
10.1016/0167-5699(90)90097-S
10.1107/S0907444910045749
10.4049/jimmunol.1000424
10.3389/fimmu.2019.01205
10.1073/pnas.0802736105
10.1016/j.jviromet.2009.02.014
10.1126/science.7716543
10.1084/jem.20121977
10.1371/journal.pone.0181134
10.1126/science.1111781
10.1038/s41577-018-0061-z
10.1016/j.immuni.2006.03.006
10.3389/fimmu.2019.01296
10.1007/s12272-019-01143-y
10.3389/fimmu.2016.00030
10.1084/jem.20020797
10.3389/fimmu.2019.01179
10.1016/j.cell.2018.10.014
10.1016/j.virol.2006.04.043
10.1128/jvi.70.3.1863-1872.1996
10.1084/jem.185.4.795
10.1007/s00251-002-0526-9
10.3389/fimmu.2014.00170
10.1126/science.287.5455.1031
10.1016/j.jim.2014.03.017
10.1126/science.aac9475
10.4049/jimmunol.1900928
10.3389/fimmu.2017.01061
10.1107/S0907444910007493
10.1371/journal.ppat.1004671
10.1016/j.jim.2014.01.004
10.1093/protein/gzq002
10.1038/35869
10.1155/2015/346714
10.1016/j.celrep.2018.07.069
10.1107/S0907444909042073
10.1016/j.it.2018.12.003
10.1038/nature12053
10.1126/science.1218231
10.1038/nature06890
10.1038/ni.3518
10.1002/eji.1830270517
10.1038/358066a0
10.1084/jem.20072525
10.1107/S0907444905007808
10.1107/S2059798317017235
10.1016/j.cell.2018.10.028
10.1038/s41467-018-05459-z
10.1073/pnas.95.9.5199
10.1038/nprot.2006.94
10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W
10.1016/j.trim.2007.06.001
10.1038/s41571-019-0182-8
10.1016/j.cell.2016.07.029
10.1016/0092-8674(94)90550-9
10.1038/nprot.2016.102
10.1107/S0907444909042589
10.4049/jimmunol.160.10.4951
10.1128/JVI.00923-17
10.1007/978-3-642-75442-5_35
ContentType Journal Article
Copyright The Author(s) 2022
2022. The Author(s).
The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2022
– notice: 2022. The Author(s).
– notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
88I
8FE
8FH
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
GNUQQ
HCIFZ
LK8
M2P
M7P
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.1038/s42003-022-03183-5
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest Central (purchase pre-March 2016)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
ProQuest Central Student
SciTech Premium Collection
ProQuest Biological Science Collection
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
Biological Science Database
ProQuest SciTech Collection
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Publicly Available Content Database


CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2399-3642
EndPage 17
ExternalDocumentID oai_doaj_org_article_059bf3a2d5d44706ba2a0a0de0b49e26
PMC8960791
35347236
10_1038_s42003_022_03183_5
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
  grantid: UM1AI126619
  funderid: https://doi.org/10.13039/100000060
– fundername: U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases 43211234
– fundername: Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation)
  grantid: OPP1108533
  funderid: https://doi.org/10.13039/100000865
– fundername: NIAID NIH HHS
  grantid: UM1 AI126619
– fundername: NIAID NIH HHS
  grantid: UM1 AI164567
– fundername: NIAID NIH HHS
  grantid: P30 AI064518
– fundername: Medical Research Council
  grantid: MR/T000503/1
– fundername: ;
– fundername: ;
  grantid: UM1AI126619
– fundername: ;
  grantid: OPP1108533
GroupedDBID 0R~
53G
88I
AAJSJ
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
AFKRA
AJTQC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BBNVY
BCNDV
BENPR
BHPHI
C6C
CCPQU
DWQXO
EBLON
EBS
GNUQQ
GROUPED_DOAJ
HCIFZ
HYE
M2P
M7P
M~E
NAO
O9-
OK1
PGMZT
PIMPY
RNT
RPM
SNYQT
AASML
AAYXX
AFFHD
CITATION
PHGZM
PHGZT
PQGLB
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FE
8FH
8FK
AARCD
LK8
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c540t-4a31e03c181f37db9db85bac5373619f2d5977a336e06c3fe7d3abb0f5b96f1a3
IEDL.DBID DOA
ISICitedReferencesCount 19
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000774059200005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2399-3642
IngestDate Tue Oct 14 18:58:38 EDT 2025
Tue Nov 04 01:57:22 EST 2025
Thu Oct 02 03:45:03 EDT 2025
Wed Aug 13 07:09:17 EDT 2025
Mon Jul 21 06:03:34 EDT 2025
Tue Nov 18 22:20:41 EST 2025
Sat Nov 29 04:16:55 EST 2025
Fri Feb 21 02:40:05 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2022. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c540t-4a31e03c181f37db9db85bac5373619f2d5977a336e06c3fe7d3abb0f5b96f1a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-9101-7478
0000-0002-3834-1893
0000-0002-8131-5914
0000-0002-3877-9780
0000-0001-7399-7954
0000-0001-8162-8358
0000-0003-4446-1194
0000-0002-0587-7560
0000-0002-4080-1350
0000-0002-1075-870X
0000-0002-7266-4354
0000-0001-6551-4713
0000-0003-4093-8346
0000-0002-7643-9023
OpenAccessLink https://doaj.org/article/059bf3a2d5d44706ba2a0a0de0b49e26
PMID 35347236
PQID 2644235801
PQPubID 4669726
PageCount 17
ParticipantIDs doaj_primary_oai_doaj_org_article_059bf3a2d5d44706ba2a0a0de0b49e26
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8960791
proquest_miscellaneous_2644938057
proquest_journals_2644235801
pubmed_primary_35347236
crossref_citationtrail_10_1038_s42003_022_03183_5
crossref_primary_10_1038_s42003_022_03183_5
springer_journals_10_1038_s42003_022_03183_5
PublicationCentury 2000
PublicationDate 2022-03-28
PublicationDateYYYYMMDD 2022-03-28
PublicationDate_xml – month: 03
  year: 2022
  text: 2022-03-28
  day: 28
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Communications biology
PublicationTitleAbbrev Commun Biol
PublicationTitleAlternate Commun Biol
PublicationYear 2022
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Andre (CR4) 2018; 175
Kraemer (CR32) 2015; 2015
Marin (CR36) 2003; 54
Rolle, Meyer, Calderazzo, Jager, Momburg (CR26) 2018; 24
Colonna, Samaridis (CR8) 1995; 268
Lowry, Zehring (CR53) 2017; 8
Liao (CR74) 2013; 496
CR39
Winn (CR66) 2011; 67
Liao (CR76) 2006; 353
Lee (CR22) 1998; 95
CR34
CR77
Haynes (CR79) 2005; 308
Braud, Jones, McMichael (CR10) 1997; 27
van Hall (CR19) 2019; 7
Kaiser, Pizarro, Kerns, Strong (CR25) 2008; 105
Yokoyama, Kim (CR2) 2006; 24
Tian (CR60) 2016; 166
Emsley, Lohkamp, Scott, Cowtan (CR68) 2010; 66
Guillerey, Huntington, Smyth (CR52) 2016; 17
Giltiay, Giordano, Clark (CR40) 2019; 203
DeKosky (CR43) 2016; 113
Lampen (CR37) 2013; 53
Walters (CR31) 2018; 9
Kepler (CR41) 2014; 5
Karplus, Diederichs (CR64) 2012; 336
Benatuil, Perez, Belk, Hsieh (CR83) 2010; 23
Yang (CR80) 2013; 210
Wrammert (CR72) 2008; 453
Pende (CR9) 2019; 10
Moody (CR58) 2014; 88
Hansen (CR30) 2016; 351
Sullivan (CR51) 2015; 10
O’Callaghan (CR62) 1998; 1
Ljunggren, Karre (CR6) 1985; 162
Hu, Wang, Huang, Sui, Xu (CR16) 2019; 10
Tomasec (CR50) 2000; 287
Liao (CR73) 2009; 158
Ravindranath (CR47) 2010; 47
Chao (CR82) 2006; 1
Yu, Netuschil, Lybarger, Connolly, Hansen (CR35) 2002; 168
Sanchez (CR57) 2014; 409
McKenna, Takemoto, Terasaki (CR48) 2000; 69
Winter (CR63) 2018; 74
Liao (CR78) 2011; 208
Llano (CR24) 1998; 28
Creelan, Antonia (CR54) 2019; 16
Karlhofer, Ribaudo, Yokoyama (CR7) 1992; 358
Braud (CR12) 1998; 391
Saunders (CR75) 2019; 10
Morales-Buenrostro (CR44) 2008; 86
Ravindranath, Kaneku, El-Awar, Morales-Buenrostro, Terasaki (CR46) 2010; 185
Souza-Fonseca-Guimaraes, Cursons, Huntington (CR18) 2019; 40
Chiossone, Dumas, Vienne, Vivier (CR3) 2018; 18
van Montfoort (CR20) 2018; 175
Sanchez (CR56) 2014; 409
Klingemann, Boissel, Toneguzzo (CR55) 2016; 7
Lee, Goodlett, Ishitani, Marquardt, Geraghty (CR21) 1998; 160
DeKosky (CR42) 2015; 21
Afonine (CR67) 2012; 68
Aldrich (CR23) 1994; 79
van Meijgaarden (CR28) 2015; 11
Kraemer, Blasczyk, Bade-Doeding (CR15) 2014; 2014
Krissinel, Henrick (CR70) 2007; 372
Ljunggren, Karre (CR5) 1990; 11
Andre (CR13) 1999; 29
Kim (CR17) 2019; 42
Petrie (CR38) 2008; 205
Vagin, Teplyakov (CR65) 2010; 66
Brooks, Posch, Scorzelli, Borrego, Coligan (CR11) 1997; 185
Joosten (CR29) 2010; 6
Mahapatra (CR14) 2017; 12
Walter (CR61) 2005; 61
Alberu (CR45) 2007; 18
Hickey, Valenzuela, Reed (CR49) 2016; 7
Moore, Sodroski (CR81) 1996; 70
von Boehmer (CR59) 2016; 11
Raulet (CR1) 2006; 18
Michaelsson (CR27) 2002; 196
Krissinel, Henrick (CR71) 2004; 60
Sensi (CR33) 2009; 21
Chen (CR69) 2010; 66
G Winter (3183_CR63) 2018; 74
L Chiossone (3183_CR3) 2018; 18
HG Ljunggren (3183_CR6) 1985; 162
A Vagin (3183_CR65) 2010; 66
BF Haynes (3183_CR79) 2005; 308
LE Lowry (3183_CR53) 2017; 8
N Lee (3183_CR22) 1998; 95
M Colonna (3183_CR8) 1995; 268
CJ Aldrich (3183_CR23) 1994; 79
W Hu (3183_CR16) 2019; 10
N Kim (3183_CR17) 2019; 42
G Chao (3183_CR82) 2006; 1
V Braud (3183_CR10) 1997; 27
VB Chen (3183_CR69) 2010; 66
P Andre (3183_CR4) 2018; 175
RM McKenna (3183_CR48) 2000; 69
S Mahapatra (3183_CR14) 2017; 12
TS Walter (3183_CR61) 2005; 61
P Emsley (3183_CR68) 2010; 66
M Sensi (3183_CR33) 2009; 21
MD Winn (3183_CR66) 2011; 67
J Alberu (3183_CR45) 2007; 18
NV Giltiay (3183_CR40) 2019; 203
G Yang (3183_CR80) 2013; 210
M Llano (3183_CR24) 1998; 28
J Michaelsson (3183_CR27) 2002; 196
R Marin (3183_CR36) 2003; 54
MH Lampen (3183_CR37) 2013; 53
E Krissinel (3183_CR70) 2007; 372
DH Raulet (3183_CR1) 2006; 18
HX Liao (3183_CR76) 2006; 353
MH Ravindranath (3183_CR47) 2010; 47
BC Creelan (3183_CR54) 2019; 16
PA Karplus (3183_CR64) 2012; 336
AG Brooks (3183_CR11) 1997; 185
J Wrammert (3183_CR72) 2008; 453
3183_CR39
JP Moore (3183_CR81) 1996; 70
HX Liao (3183_CR73) 2009; 158
LC Sullivan (3183_CR51) 2015; 10
P Andre (3183_CR13) 1999; 29
CA O’Callaghan (3183_CR62) 1998; 1
3183_CR34
L Benatuil (3183_CR83) 2010; 23
VM Braud (3183_CR12) 1998; 391
N Lee (3183_CR21) 1998; 160
3183_CR77
T Kraemer (3183_CR32) 2015; 2015
LE Morales-Buenrostro (3183_CR44) 2008; 86
D Pende (3183_CR9) 2019; 10
SA Joosten (3183_CR29) 2010; 6
M Tian (3183_CR60) 2016; 166
A Rolle (3183_CR26) 2018; 24
LC Walters (3183_CR31) 2018; 9
MH Ravindranath (3183_CR46) 2010; 185
SG Hansen (3183_CR30) 2016; 351
C Guillerey (3183_CR52) 2016; 17
WM Yokoyama (3183_CR2) 2006; 24
N van Montfoort (3183_CR20) 2018; 175
T van Hall (3183_CR19) 2019; 7
MA Moody (3183_CR58) 2014; 88
PV Afonine (3183_CR67) 2012; 68
HG Ljunggren (3183_CR5) 1990; 11
YY Yu (3183_CR35) 2002; 168
TB Kepler (3183_CR41) 2014; 5
AM Sanchez (3183_CR57) 2014; 409
KO Saunders (3183_CR75) 2019; 10
MJ Hickey (3183_CR49) 2016; 7
BJ DeKosky (3183_CR43) 2016; 113
BJ DeKosky (3183_CR42) 2015; 21
H Klingemann (3183_CR55) 2016; 7
P Tomasec (3183_CR50) 2000; 287
FM Karlhofer (3183_CR7) 1992; 358
T Kraemer (3183_CR15) 2014; 2014
EJ Petrie (3183_CR38) 2008; 205
E Krissinel (3183_CR71) 2004; 60
HX Liao (3183_CR78) 2011; 208
KE van Meijgaarden (3183_CR28) 2015; 11
AM Sanchez (3183_CR56) 2014; 409
BK Kaiser (3183_CR25) 2008; 105
L von Boehmer (3183_CR59) 2016; 11
HX Liao (3183_CR74) 2013; 496
F Souza-Fonseca-Guimaraes (3183_CR18) 2019; 40
References_xml – volume: 47
  start-page: 1121
  year: 2010
  end-page: 1131
  ident: CR47
  article-title: HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: relevance to human natural HLA antibodies
  publication-title: Mol. Immunol.
  doi: 10.1016/j.molimm.2009.10.024
– volume: 1
  start-page: 531
  year: 1998
  end-page: 541
  ident: CR62
  article-title: Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E
  publication-title: Mol. Cell
  doi: 10.1016/S1097-2765(00)80053-2
– volume: 10
  start-page: e0135972
  year: 2015
  ident: CR51
  article-title: The presence of HLA-E-restricted, CMV-specific CD8+ T cells in the blood of lung transplant recipients correlates with chronic allograft rejection
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0135972
– ident: CR39
– volume: 29
  start-page: 1076
  year: 1999
  end-page: 1085
  ident: CR13
  article-title: Differential regulation of killer cell Ig-like receptors and CD94 lectin-like dimers on NK and T lymphocytes from HIV-1-infected individuals
  publication-title: Eur. J. Immunol.
  doi: 10.1002/(SICI)1521-4141(199904)29:04<1076::AID-IMMU1076>3.0.CO;2-Z
– volume: 6
  start-page: e1000782
  year: 2010
  ident: CR29
  article-title: Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1000782
– volume: 21
  start-page: 257
  year: 2009
  end-page: 268
  ident: CR33
  article-title: Peptides with dual binding specificity for HLA-A2 and HLA-E are encoded by alternatively spliced isoforms of the antioxidant enzyme peroxiredoxin 5
  publication-title: Int. Immunol.
  doi: 10.1093/intimm/dxn141
– volume: 208
  start-page: 2237
  year: 2011
  end-page: 2249
  ident: CR78
  article-title: Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20110363
– volume: 68
  start-page: 352
  year: 2012
  end-page: 367
  ident: CR67
  article-title: Towards automated crystallographic structure refinement with phenix.refine
  publication-title: Acta Crystallogr. D. Biol. Crystallogr.
  doi: 10.1107/S0907444912001308
– volume: 88
  start-page: 3329
  year: 2014
  end-page: 3339
  ident: CR58
  article-title: Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques
  publication-title: J. Virol.
  doi: 10.1128/JVI.03309-13
– volume: 372
  start-page: 774
  year: 2007
  end-page: 797
  ident: CR70
  article-title: Inference of macromolecular assemblies from crystalline state
  publication-title: J. Mol. Biol.
  doi: 10.1016/j.jmb.2007.05.022
– volume: 69
  start-page: 319
  year: 2000
  end-page: 326
  ident: CR48
  article-title: Anti-HLA antibodies after solid organ
  publication-title: Transplant. Transplant.
  doi: 10.1097/00007890-200002150-00001
– volume: 7
  start-page: 263
  year: 2019
  ident: CR19
  article-title: Monalizumab: inhibiting the novel immune checkpoint NKG2A
  publication-title: J. Immunother. Cancer
  doi: 10.1186/s40425-019-0761-3
– volume: 21
  start-page: 86
  year: 2015
  end-page: 91
  ident: CR42
  article-title: In-depth determination and analysis of the human paired heavy- and light-chain antibody repertoire
  publication-title: Nat. Med.
  doi: 10.1038/nm.3743
– ident: CR77
– volume: 18
  start-page: 145
  year: 2006
  end-page: 150
  ident: CR1
  article-title: Missing self recognition and self tolerance of natural killer (NK) cells
  publication-title: Semin Immunol.
  doi: 10.1016/j.smim.2006.03.003
– volume: 162
  start-page: 1745
  year: 1985
  end-page: 1759
  ident: CR6
  article-title: Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.162.6.1745
– volume: 2014
  start-page: 352160
  year: 2014
  ident: CR15
  article-title: HLA-E: a novel player for histocompatibility
  publication-title: J. Immunol. Res.
  doi: 10.1155/2014/352160
– volume: 113
  start-page: E2636
  year: 2016
  end-page: E2645
  ident: CR43
  article-title: Large-scale sequence and structural comparisons of human naive and antigen-experienced antibody repertoires
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1525510113
– volume: 168
  start-page: 3145
  year: 2002
  end-page: 3149
  ident: CR35
  article-title: Cutting edge: single-chain trimers of MHC class I molecules form stable structures that potently stimulate antigen-specific T cells and B cells
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.168.7.3145
– volume: 53
  start-page: 126
  year: 2013
  end-page: 131
  ident: CR37
  article-title: Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2
  publication-title: Mol. Immunol.
  doi: 10.1016/j.molimm.2012.07.009
– volume: 86
  start-page: 1111
  year: 2008
  end-page: 1115
  ident: CR44
  article-title: “Natural” human leukocyte antigen antibodies found in nonalloimmunized healthy males
  publication-title: Transplantation
  doi: 10.1097/TP.0b013e318186d87b
– volume: 60
  start-page: 2256
  year: 2004
  end-page: 2268
  ident: CR71
  article-title: Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions
  publication-title: Acta Crystallogr. D. Biol. Crystallogr.
  doi: 10.1107/S0907444904026460
– volume: 7
  start-page: 91
  year: 2016
  ident: CR55
  article-title: Natural killer cells for immunotherapy-advantages of the NK-92 cell line over blood NK cells
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2016.00091
– volume: 11
  start-page: 237
  year: 1990
  end-page: 244
  ident: CR5
  article-title: In search of the ‘missing self’: MHC molecules and NK
  publication-title: Cell Recognit. Immunol. Today
  doi: 10.1016/0167-5699(90)90097-S
– volume: 67
  start-page: 235
  year: 2011
  end-page: 242
  ident: CR66
  article-title: Overview of the CCP4 suite and current developments
  publication-title: Acta Crystallogr. D. Biol. Crystallogr.
  doi: 10.1107/S0907444910045749
– volume: 185
  start-page: 1935
  year: 2010
  end-page: 1948
  ident: CR46
  article-title: Antibodies to HLA-E in nonalloimmunized males: pattern of HLA-Ia reactivity of anti-HLA-E-positive sera
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1000424
– volume: 10
  start-page: 1205
  year: 2019
  ident: CR16
  article-title: Cancer immunotherapy based on natural killer cells: current progress and new opportunities
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2019.01205
– volume: 105
  start-page: 6696
  year: 2008
  end-page: 6701
  ident: CR25
  article-title: Structural basis for NKG2A/CD94 recognition of HLA-E
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.0802736105
– volume: 158
  start-page: 171
  year: 2009
  end-page: 179
  ident: CR73
  article-title: High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies
  publication-title: J. Virol. Methods
  doi: 10.1016/j.jviromet.2009.02.014
– volume: 268
  start-page: 405
  year: 1995
  end-page: 408
  ident: CR8
  article-title: Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells
  publication-title: Science
  doi: 10.1126/science.7716543
– volume: 210
  start-page: 241
  year: 2013
  end-page: 256
  ident: CR80
  article-title: Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20121977
– volume: 12
  start-page: e0181134
  year: 2017
  ident: CR14
  article-title: High-resolution phenotyping identifies NK cell subsets that distinguish healthy children from adults
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0181134
– volume: 308
  start-page: 1906
  year: 2005
  end-page: 1908
  ident: CR79
  article-title: Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies
  publication-title: Science
  doi: 10.1126/science.1111781
– volume: 18
  start-page: 671
  year: 2018
  end-page: 688
  ident: CR3
  article-title: Natural killer cells and other innate lymphoid cells in cancer
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/s41577-018-0061-z
– volume: 24
  start-page: 249
  year: 2006
  end-page: 257
  ident: CR2
  article-title: How do natural killer cells find self to achieve tolerance?
  publication-title: Immunity
  doi: 10.1016/j.immuni.2006.03.006
– volume: 10
  start-page: 1296
  year: 2019
  ident: CR75
  article-title: Conceptual approaches to modulating antibody effector functions and circulation half-life
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2019.01296
– volume: 160
  start-page: 4951
  year: 1998
  end-page: 4960
  ident: CR21
  article-title: HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences
  publication-title: J. Immunol.
– volume: 42
  start-page: 591
  year: 2019
  end-page: 606
  ident: CR17
  article-title: Natural killer cells as a promising therapeutic target for cancer immunotherapy
  publication-title: Arch. Pharm. Res.
  doi: 10.1007/s12272-019-01143-y
– volume: 7
  start-page: 30
  year: 2016
  ident: CR49
  article-title: Alloantibody generation and effector function following sensitization to human leukocyte antigen
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2016.00030
– volume: 196
  start-page: 1403
  year: 2002
  end-page: 1414
  ident: CR27
  article-title: A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20020797
– volume: 10
  start-page: 1179
  year: 2019
  ident: CR9
  article-title: Killer Ig-like receptors (KIRs): their role in NK cell modulation and developments leading to their clinical exploitation
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2019.01179
– volume: 175
  start-page: 1731
  year: 2018
  end-page: 1743 e1713
  ident: CR4
  article-title: Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells
  publication-title: Cell
  doi: 10.1016/j.cell.2018.10.014
– volume: 353
  start-page: 268
  year: 2006
  end-page: 282
  ident: CR76
  article-title: A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses
  publication-title: Virology
  doi: 10.1016/j.virol.2006.04.043
– volume: 70
  start-page: 1863
  year: 1996
  end-page: 1872
  ident: CR81
  article-title: Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein
  publication-title: J. Virol.
  doi: 10.1128/jvi.70.3.1863-1872.1996
– volume: 185
  start-page: 795
  year: 1997
  end-page: 800
  ident: CR11
  article-title: NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.185.4.795
– volume: 54
  start-page: 767
  year: 2003
  end-page: 775
  ident: CR36
  article-title: Analysis of HLA-E expression in human tumors
  publication-title: Immunogenetics
  doi: 10.1007/s00251-002-0526-9
– volume: 5
  start-page: 170
  year: 2014
  ident: CR41
  article-title: Reconstructing a B-cell clonal lineage. II. mutation, selection, and affinity maturation
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2014.00170
– volume: 287
  start-page: 1031
  year: 2000
  ident: CR50
  article-title: Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40
  publication-title: Science
  doi: 10.1126/science.287.5455.1031
– volume: 409
  start-page: 31
  year: 2014
  end-page: 43
  ident: CR57
  article-title: The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-gamma ELISpot) assay
  publication-title: J. Immunol. Methods
  doi: 10.1016/j.jim.2014.03.017
– volume: 351
  start-page: 714
  year: 2016
  end-page: 720
  ident: CR30
  article-title: Broadly targeted CD8(+) T cell responses restricted by major histocompatibility complex E
  publication-title: Science
  doi: 10.1126/science.aac9475
– volume: 203
  start-page: 3095
  year: 2019
  end-page: 3104
  ident: CR40
  article-title: The plasticity of newly formed B cells
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1900928
– volume: 8
  start-page: 1061
  year: 2017
  ident: CR53
  article-title: Potentiation of natural killer cells for cancer immunotherapy: a review of literature
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2017.01061
– volume: 66
  start-page: 486
  year: 2010
  end-page: 501
  ident: CR68
  article-title: Features and development of Coot
  publication-title: Acta Crystallogr. D. Biol. Crystallogr.
  doi: 10.1107/S0907444910007493
– volume: 11
  start-page: e1004671
  year: 2015
  ident: CR28
  article-title: Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1004671
– volume: 409
  start-page: 117
  year: 2014
  end-page: 130
  ident: CR56
  article-title: Development of a contemporary globally diverse HIV viral panel by the EQAPOL program
  publication-title: J. Immunol. Methods
  doi: 10.1016/j.jim.2014.01.004
– volume: 23
  start-page: 155
  year: 2010
  end-page: 159
  ident: CR83
  article-title: An improved yeast transformation method for the generation of very large human antibody libraries
  publication-title: Protein Eng. Des. Sel.
  doi: 10.1093/protein/gzq002
– volume: 391
  start-page: 795
  year: 1998
  end-page: 799
  ident: CR12
  article-title: HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
  publication-title: Nature
  doi: 10.1038/35869
– volume: 2015
  start-page: 346714
  year: 2015
  ident: CR32
  article-title: HLA-E: presentation of a broader peptide repertoire impacts the cellular immune response-implications on HSCT outcome
  publication-title: Stem Cells Int
  doi: 10.1155/2015/346714
– volume: 24
  start-page: 1967
  year: 2018
  end-page: 1976 e1964
  ident: CR26
  article-title: Distinct HLA-E peptide complexes modify antibody-driven effector functions of adaptive NK cells
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2018.07.069
– volume: 66
  start-page: 12
  year: 2010
  end-page: 21
  ident: CR69
  article-title: MolProbity: all-atom structure validation for macromolecular crystallography
  publication-title: Acta Crystallogr. D. Biol. Crystallogr.
  doi: 10.1107/S0907444909042073
– volume: 40
  start-page: 142
  year: 2019
  end-page: 158
  ident: CR18
  article-title: The emergence of natural killer cells as a major target in cancer immunotherapy
  publication-title: Trends Immunol.
  doi: 10.1016/j.it.2018.12.003
– volume: 496
  start-page: 469
  year: 2013
  end-page: 476
  ident: CR74
  article-title: Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
  publication-title: Nature
  doi: 10.1038/nature12053
– volume: 336
  start-page: 1030
  year: 2012
  end-page: 1033
  ident: CR64
  article-title: Linking crystallographic model and data quality
  publication-title: Science
  doi: 10.1126/science.1218231
– volume: 453
  start-page: 667
  year: 2008
  end-page: 671
  ident: CR72
  article-title: Rapid cloning of high-affinity human monoclonal antibodies against influenza virus
  publication-title: Nature
  doi: 10.1038/nature06890
– volume: 17
  start-page: 1025
  year: 2016
  end-page: 1036
  ident: CR52
  article-title: Targeting natural killer cells in cancer immunotherapy
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.3518
– volume: 27
  start-page: 1164
  year: 1997
  end-page: 1169
  ident: CR10
  article-title: The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.1830270517
– volume: 358
  start-page: 66
  year: 1992
  end-page: 70
  ident: CR7
  article-title: MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells
  publication-title: Nature
  doi: 10.1038/358066a0
– volume: 205
  start-page: 725
  year: 2008
  end-page: 735
  ident: CR38
  article-title: CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20072525
– volume: 61
  start-page: 651
  year: 2005
  end-page: 657
  ident: CR61
  article-title: A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization
  publication-title: Acta Crystallogr. D. Biol. Crystallogr.
  doi: 10.1107/S0907444905007808
– volume: 74
  start-page: 85
  year: 2018
  end-page: 97
  ident: CR63
  article-title: DIALS: implementation and evaluation of a new integration package
  publication-title: Acta Crystallogr. D. Struct. Biol.
  doi: 10.1107/S2059798317017235
– volume: 175
  start-page: 1744
  year: 2018
  end-page: 1755 e1715
  ident: CR20
  article-title: NKG2A blockade potentiates CD8 T cell immunity induced by cancer vaccines
  publication-title: Cell
  doi: 10.1016/j.cell.2018.10.028
– volume: 9
  year: 2018
  ident: CR31
  article-title: Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-05459-z
– ident: CR34
– volume: 95
  start-page: 5199
  year: 1998
  end-page: 5204
  ident: CR22
  article-title: HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.95.9.5199
– volume: 66
  start-page: 22
  year: 2010
  end-page: 25
  ident: CR65
  article-title: Molecular replacement with MOLREP
  publication-title: Acta Crystallogr. D. Biol. Crystallogr.
– volume: 1
  start-page: 755
  year: 2006
  end-page: 768
  ident: CR82
  article-title: Isolating and engineering human antibodies using yeast surface display
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2006.94
– volume: 28
  start-page: 2854
  year: 1998
  end-page: 2863
  ident: CR24
  article-title: HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer
  publication-title: Eur. J. Immunol.
  doi: 10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W
– volume: 18
  start-page: 166
  year: 2007
  end-page: 171
  ident: CR45
  article-title: A non-allogeneic stimulus triggers the production of de novo HLA antibodies in healthy adults
  publication-title: Transpl. Immunol.
  doi: 10.1016/j.trim.2007.06.001
– volume: 16
  start-page: 277
  year: 2019
  end-page: 278
  ident: CR54
  article-title: The NKG2A immune checkpoint-a new direction in cancer immunotherapy
  publication-title: Nat. Rev. Clin. Oncol.
  doi: 10.1038/s41571-019-0182-8
– volume: 166
  start-page: 1471
  year: 2016
  end-page: 1484 e1418
  ident: CR60
  article-title: Induction of HIV neutralizing antibody lineages in mice with diverse precursor repertoires
  publication-title: Cell
  doi: 10.1016/j.cell.2016.07.029
– volume: 79
  start-page: 649
  year: 1994
  end-page: 658
  ident: CR23
  article-title: Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen
  publication-title: Cell
  doi: 10.1016/0092-8674(94)90550-9
– volume: 11
  start-page: 1908
  year: 2016
  end-page: 1923
  ident: CR59
  article-title: Sequencing and cloning of antigen-specific antibodies from mouse memory B cells
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2016.102
– volume: 162
  start-page: 1745
  year: 1985
  ident: 3183_CR6
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.162.6.1745
– volume: 11
  start-page: e1004671
  year: 2015
  ident: 3183_CR28
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1004671
– volume: 168
  start-page: 3145
  year: 2002
  ident: 3183_CR35
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.168.7.3145
– volume: 86
  start-page: 1111
  year: 2008
  ident: 3183_CR44
  publication-title: Transplantation
  doi: 10.1097/TP.0b013e318186d87b
– volume: 21
  start-page: 86
  year: 2015
  ident: 3183_CR42
  publication-title: Nat. Med.
  doi: 10.1038/nm.3743
– volume: 69
  start-page: 319
  year: 2000
  ident: 3183_CR48
  publication-title: Transplant. Transplant.
  doi: 10.1097/00007890-200002150-00001
– volume: 11
  start-page: 1908
  year: 2016
  ident: 3183_CR59
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2016.102
– volume: 17
  start-page: 1025
  year: 2016
  ident: 3183_CR52
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.3518
– volume: 2015
  start-page: 346714
  year: 2015
  ident: 3183_CR32
  publication-title: Stem Cells Int
  doi: 10.1155/2015/346714
– volume: 205
  start-page: 725
  year: 2008
  ident: 3183_CR38
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20072525
– volume: 196
  start-page: 1403
  year: 2002
  ident: 3183_CR27
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20020797
– volume: 5
  start-page: 170
  year: 2014
  ident: 3183_CR41
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2014.00170
– volume: 287
  start-page: 1031
  year: 2000
  ident: 3183_CR50
  publication-title: Science
  doi: 10.1126/science.287.5455.1031
– volume: 185
  start-page: 795
  year: 1997
  ident: 3183_CR11
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.185.4.795
– volume: 47
  start-page: 1121
  year: 2010
  ident: 3183_CR47
  publication-title: Mol. Immunol.
  doi: 10.1016/j.molimm.2009.10.024
– volume: 18
  start-page: 145
  year: 2006
  ident: 3183_CR1
  publication-title: Semin Immunol.
  doi: 10.1016/j.smim.2006.03.003
– volume: 7
  start-page: 263
  year: 2019
  ident: 3183_CR19
  publication-title: J. Immunother. Cancer
  doi: 10.1186/s40425-019-0761-3
– volume: 1
  start-page: 755
  year: 2006
  ident: 3183_CR82
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2006.94
– volume: 28
  start-page: 2854
  year: 1998
  ident: 3183_CR24
  publication-title: Eur. J. Immunol.
  doi: 10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W
– volume: 336
  start-page: 1030
  year: 2012
  ident: 3183_CR64
  publication-title: Science
  doi: 10.1126/science.1218231
– volume: 24
  start-page: 249
  year: 2006
  ident: 3183_CR2
  publication-title: Immunity
  doi: 10.1016/j.immuni.2006.03.006
– volume: 66
  start-page: 22
  year: 2010
  ident: 3183_CR65
  publication-title: Acta Crystallogr. D. Biol. Crystallogr.
  doi: 10.1107/S0907444909042589
– volume: 2014
  start-page: 352160
  year: 2014
  ident: 3183_CR15
  publication-title: J. Immunol. Res.
  doi: 10.1155/2014/352160
– volume: 160
  start-page: 4951
  year: 1998
  ident: 3183_CR21
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.160.10.4951
– volume: 7
  start-page: 91
  year: 2016
  ident: 3183_CR55
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2016.00091
– volume: 88
  start-page: 3329
  year: 2014
  ident: 3183_CR58
  publication-title: J. Virol.
  doi: 10.1128/JVI.03309-13
– volume: 105
  start-page: 6696
  year: 2008
  ident: 3183_CR25
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.0802736105
– volume: 79
  start-page: 649
  year: 1994
  ident: 3183_CR23
  publication-title: Cell
  doi: 10.1016/0092-8674(94)90550-9
– volume: 27
  start-page: 1164
  year: 1997
  ident: 3183_CR10
  publication-title: Eur. J. Immunol.
  doi: 10.1002/eji.1830270517
– volume: 7
  start-page: 30
  year: 2016
  ident: 3183_CR49
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2016.00030
– volume: 210
  start-page: 241
  year: 2013
  ident: 3183_CR80
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20121977
– volume: 24
  start-page: 1967
  year: 2018
  ident: 3183_CR26
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2018.07.069
– volume: 268
  start-page: 405
  year: 1995
  ident: 3183_CR8
  publication-title: Science
  doi: 10.1126/science.7716543
– volume: 496
  start-page: 469
  year: 2013
  ident: 3183_CR74
  publication-title: Nature
  doi: 10.1038/nature12053
– volume: 68
  start-page: 352
  year: 2012
  ident: 3183_CR67
  publication-title: Acta Crystallogr. D. Biol. Crystallogr.
  doi: 10.1107/S0907444912001308
– volume: 185
  start-page: 1935
  year: 2010
  ident: 3183_CR46
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1000424
– volume: 10
  start-page: 1205
  year: 2019
  ident: 3183_CR16
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2019.01205
– volume: 18
  start-page: 166
  year: 2007
  ident: 3183_CR45
  publication-title: Transpl. Immunol.
  doi: 10.1016/j.trim.2007.06.001
– ident: 3183_CR77
  doi: 10.1128/JVI.00923-17
– volume: 95
  start-page: 5199
  year: 1998
  ident: 3183_CR22
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.95.9.5199
– volume: 40
  start-page: 142
  year: 2019
  ident: 3183_CR18
  publication-title: Trends Immunol.
  doi: 10.1016/j.it.2018.12.003
– volume: 175
  start-page: 1744
  year: 2018
  ident: 3183_CR20
  publication-title: Cell
  doi: 10.1016/j.cell.2018.10.028
– volume: 11
  start-page: 237
  year: 1990
  ident: 3183_CR5
  publication-title: Cell Recognit. Immunol. Today
  doi: 10.1016/0167-5699(90)90097-S
– volume: 9
  year: 2018
  ident: 3183_CR31
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-05459-z
– volume: 1
  start-page: 531
  year: 1998
  ident: 3183_CR62
  publication-title: Mol. Cell
  doi: 10.1016/S1097-2765(00)80053-2
– volume: 409
  start-page: 117
  year: 2014
  ident: 3183_CR56
  publication-title: J. Immunol. Methods
  doi: 10.1016/j.jim.2014.01.004
– volume: 113
  start-page: E2636
  year: 2016
  ident: 3183_CR43
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1525510113
– volume: 61
  start-page: 651
  year: 2005
  ident: 3183_CR61
  publication-title: Acta Crystallogr. D. Biol. Crystallogr.
  doi: 10.1107/S0907444905007808
– volume: 60
  start-page: 2256
  year: 2004
  ident: 3183_CR71
  publication-title: Acta Crystallogr. D. Biol. Crystallogr.
  doi: 10.1107/S0907444904026460
– volume: 6
  start-page: e1000782
  year: 2010
  ident: 3183_CR29
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1000782
– volume: 203
  start-page: 3095
  year: 2019
  ident: 3183_CR40
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1900928
– volume: 67
  start-page: 235
  year: 2011
  ident: 3183_CR66
  publication-title: Acta Crystallogr. D. Biol. Crystallogr.
  doi: 10.1107/S0907444910045749
– volume: 54
  start-page: 767
  year: 2003
  ident: 3183_CR36
  publication-title: Immunogenetics
  doi: 10.1007/s00251-002-0526-9
– ident: 3183_CR39
– volume: 12
  start-page: e0181134
  year: 2017
  ident: 3183_CR14
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0181134
– volume: 10
  start-page: e0135972
  year: 2015
  ident: 3183_CR51
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0135972
– volume: 66
  start-page: 486
  year: 2010
  ident: 3183_CR68
  publication-title: Acta Crystallogr. D. Biol. Crystallogr.
  doi: 10.1107/S0907444910007493
– volume: 21
  start-page: 257
  year: 2009
  ident: 3183_CR33
  publication-title: Int. Immunol.
  doi: 10.1093/intimm/dxn141
– ident: 3183_CR34
  doi: 10.1007/978-3-642-75442-5_35
– volume: 158
  start-page: 171
  year: 2009
  ident: 3183_CR73
  publication-title: J. Virol. Methods
  doi: 10.1016/j.jviromet.2009.02.014
– volume: 29
  start-page: 1076
  year: 1999
  ident: 3183_CR13
  publication-title: Eur. J. Immunol.
  doi: 10.1002/(SICI)1521-4141(199904)29:04<1076::AID-IMMU1076>3.0.CO;2-Z
– volume: 53
  start-page: 126
  year: 2013
  ident: 3183_CR37
  publication-title: Mol. Immunol.
  doi: 10.1016/j.molimm.2012.07.009
– volume: 10
  start-page: 1296
  year: 2019
  ident: 3183_CR75
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2019.01296
– volume: 208
  start-page: 2237
  year: 2011
  ident: 3183_CR78
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20110363
– volume: 70
  start-page: 1863
  year: 1996
  ident: 3183_CR81
  publication-title: J. Virol.
  doi: 10.1128/jvi.70.3.1863-1872.1996
– volume: 42
  start-page: 591
  year: 2019
  ident: 3183_CR17
  publication-title: Arch. Pharm. Res.
  doi: 10.1007/s12272-019-01143-y
– volume: 358
  start-page: 66
  year: 1992
  ident: 3183_CR7
  publication-title: Nature
  doi: 10.1038/358066a0
– volume: 353
  start-page: 268
  year: 2006
  ident: 3183_CR76
  publication-title: Virology
  doi: 10.1016/j.virol.2006.04.043
– volume: 23
  start-page: 155
  year: 2010
  ident: 3183_CR83
  publication-title: Protein Eng. Des. Sel.
  doi: 10.1093/protein/gzq002
– volume: 372
  start-page: 774
  year: 2007
  ident: 3183_CR70
  publication-title: J. Mol. Biol.
  doi: 10.1016/j.jmb.2007.05.022
– volume: 175
  start-page: 1731
  year: 2018
  ident: 3183_CR4
  publication-title: Cell
  doi: 10.1016/j.cell.2018.10.014
– volume: 18
  start-page: 671
  year: 2018
  ident: 3183_CR3
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/s41577-018-0061-z
– volume: 10
  start-page: 1179
  year: 2019
  ident: 3183_CR9
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2019.01179
– volume: 8
  start-page: 1061
  year: 2017
  ident: 3183_CR53
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2017.01061
– volume: 409
  start-page: 31
  year: 2014
  ident: 3183_CR57
  publication-title: J. Immunol. Methods
  doi: 10.1016/j.jim.2014.03.017
– volume: 391
  start-page: 795
  year: 1998
  ident: 3183_CR12
  publication-title: Nature
  doi: 10.1038/35869
– volume: 74
  start-page: 85
  year: 2018
  ident: 3183_CR63
  publication-title: Acta Crystallogr. D. Struct. Biol.
  doi: 10.1107/S2059798317017235
– volume: 16
  start-page: 277
  year: 2019
  ident: 3183_CR54
  publication-title: Nat. Rev. Clin. Oncol.
  doi: 10.1038/s41571-019-0182-8
– volume: 453
  start-page: 667
  year: 2008
  ident: 3183_CR72
  publication-title: Nature
  doi: 10.1038/nature06890
– volume: 308
  start-page: 1906
  year: 2005
  ident: 3183_CR79
  publication-title: Science
  doi: 10.1126/science.1111781
– volume: 351
  start-page: 714
  year: 2016
  ident: 3183_CR30
  publication-title: Science
  doi: 10.1126/science.aac9475
– volume: 166
  start-page: 1471
  year: 2016
  ident: 3183_CR60
  publication-title: Cell
  doi: 10.1016/j.cell.2016.07.029
– volume: 66
  start-page: 12
  year: 2010
  ident: 3183_CR69
  publication-title: Acta Crystallogr. D. Biol. Crystallogr.
  doi: 10.1107/S0907444909042073
SSID ssj0001999634
Score 2.3172867
Snippet The non-classical class Ib molecule human leukocyte antigen E (HLA-E) has limited polymorphism and can bind HLA class Ia leader peptides (VL9). HLA-E-VL9...
The identification and structural analysis of HLA-E-VL9-targeting antibodies that block a natural killer (NK) cell receptor pathway and regulate NK function in...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 271
SubjectTerms 13/1
13/106
13/109
13/31
14/28
14/34
14/63
38
38/77
42
631/250/1619/382
631/250/2152/2153/1291
631/535/1266
631/61/51/1568
64/60
82
82/80
82/83
Animals
Antibodies
Biology
Biomedical and Life Sciences
Cytomegalovirus
Cytotoxicity
Cytotoxicity, Immunologic
Histocompatibility antigen HLA
Histocompatibility Antigens Class I - genetics
HLA Antigens
HLA-E Antigens
Humans
Immunoglobulin G
Immunoglobulin M
Immunoglobulins - metabolism
Killer Cells, Natural
Life Sciences
Lymphocytes B
Mice
Natural killer cells
NKG2 antigen
Peptides - metabolism
Protein Sorting Signals
SummonAdditionalLinks – databaseName: Science Database
  dbid: M2P
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaggMSF8m5oQUbiBlYdjxMnJ1SqVpVoVz2A1JvlZ7tSlSybtGr_PbaT3dUC7YVbFNuJ7ZmxP9ufZxD65L2nRlU14R484UIVRFmoCVOaWcOpVSpdFD4Wk0l1dlafjhtu3UirXIyJaaC2rYl75Ltx4o7XOmn-dfaLxKhR8XR1DKHxED0KyCaPlK4TdrraY4loHvh4V4ZCtdvxRMaKFPakzaRYm4-S2_5_Yc2_KZN_nJum6ehw838b8hw9G4Eo3hs05wV64JqX6MkQmvL2FZIn7VXnsGosTmH8wlM_1W3kHOKwmLb46HiPHJDLxITGs8iNsQ4ngrq7CXliQddcRJ3Ck-84ng9gc9u3fXszNQH5v0Y_Dw9-7B-RMRgDMQHU9YQryB0FExCBB2F1bXVVaGUKEBAWYZ7Z6MlOAZSOlga8ExaU1tQXui59ruAN2mjaxm0hzC1zPhfWlVRzV3rtdQnOAKsthQA3M5QvRCLN6Kk8Bsy4lOnEHCo5iFEGMcokRllk6POyzGzw03Fv7m9R0suc0cd2etHOz-VosjIAT-1BhYZZzgUttWKKKmpdqHXtWJmhnYWA5Wj4nVxJN0Mfl8nBZGM_q8YF2aU8NVQBKWfo7aBWy5pAAVwwCB8Xawq3VtX1lGZ6kdyCV2ExKurw3y8L1VxV6-6ueHd_K7bRUzZYC2HVDtro51fuPXpsrvtpN_-QzO03BVYyNQ
  priority: 102
  providerName: ProQuest
Title Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity
URI https://link.springer.com/article/10.1038/s42003-022-03183-5
https://www.ncbi.nlm.nih.gov/pubmed/35347236
https://www.proquest.com/docview/2644235801
https://www.proquest.com/docview/2644938057
https://pubmed.ncbi.nlm.nih.gov/PMC8960791
https://doaj.org/article/059bf3a2d5d44706ba2a0a0de0b49e26
Volume 5
WOSCitedRecordID wos000774059200005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2399-3642
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001999634
  issn: 2399-3642
  databaseCode: DOA
  dateStart: 20180101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources (ISSN International Center)
  customDbUrl:
  eissn: 2399-3642
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001999634
  issn: 2399-3642
  databaseCode: M~E
  dateStart: 20180101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 2399-3642
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001999634
  issn: 2399-3642
  databaseCode: M7P
  dateStart: 20220101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2399-3642
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001999634
  issn: 2399-3642
  databaseCode: BENPR
  dateStart: 20220101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 2399-3642
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001999634
  issn: 2399-3642
  databaseCode: PIMPY
  dateStart: 20220101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database (ProQuest)
  customDbUrl:
  eissn: 2399-3642
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001999634
  issn: 2399-3642
  databaseCode: M2P
  dateStart: 20220101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3daxQxEA_aKvgiftbTekTwTUNzmexm97GVKxV7xyEK51PIJz0oe6W3SvvfO8nunT0_X3wJyybZDfPB_CaZzBDyOsbInalqJiNEJpUpmPFQM2Gs8E5yb0y-KHyqptNqPq9nN0p9pZiwLj1wR7gDNP82ghG-8FIqXlojDDfcB25lHUROts1VfcOZyrsrCceD7G_JcKgOVjKHYaXg9SzHrNiyRDlh_-9Q5q_Bkj-dmGZDdPyA3O8RJD3sVv6Q3ArNI3K3qyl5_ZjoCfrygZrG01x_D5_ahV2mYEGKXrCnJ6eHbMzOcwgzvUhBLT7QHFkernBMmhiasyQMdPqBpo196q7bZbu8WjiE7E_I5-Pxp3cnrK-iwByisZZJA6PAwaEpj6C8rb2tCmtcAQrQe4pIWcSABqAMvHQQg_JgrOWxsHUZRwaekp1m2YRnhEovQhwpH0okfiijjbaE4EDUngPixAEZrSmqXZ9iPFW6ONf5qBsq3XFBIxd05oIuBuTNZs5Fl2Djr6OPEqM2I1Ny7PwCRUb3IqP_JTIDsr9ms-41dqUTMEzXhvloQF5tulHXEp1NE5B3eUwNFULcAdnrpGKzEihAKgH4cbUlL1tL3e5pFmc5n3eFXqSq8b9v15L1Y1l_JsXz_0GKF-Se6FSCiWqf7LSXX8NLcsd9axeryyG5rebVkOwejaezj8OsYdhOxCy1Ctvd2fvJ7Mt3lnwqoA
linkProvider Directory of Open Access Journals
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LbxMxELZKAcGF9yNQwEhwAquOx_s6IFSgVaqkUQ9F6s34SSNVuyHZQvOn-I3Y3t1E4dFbD9xWXnvX9n4znll_nkHolXOOapkXhDtwhGcyIdJAQZhUzGhOjZTxoPAoG4_z4-PicAP97M7CBFplpxOjojaVDv_It8PCHY510v776TcSskaF3dUuhUYDi6Fd_PAu2_zd_if_fV8ztrd79HFA2qwCRHvrpCZcQt9S0H5pc5AZVRiVJ0rqBDLw3oRjJoRkkwCppakGZzMDUinqElWkri_BP_cKuspDZLFAFWSHq386wXsA3p7NoZBvz3kkfwXKfJQekqytfzFNwN9s2z8pmr_t08blb-_2_zZxd9Ct1tDGO41k3EUbtryHrjepNxf3kTiozuYWy9LgmKbQX9UTVQVOJVYTXzoY7ZBdchqZ3ngauD_G4kjAt-e-Tmhoy5MgM3g8xGH_A-tFXdXV-UR7z-YB-nwpo3uINsuqtI8R5oZZ18-MTaniNnXKqRSsBlYYCt6c7qF-BwGh20jsISHIqYiMAMhFAxvhYSMibETSQ2-WbaZNHJILa38IyFrWDDHEY0E1-ypalSS8Ya0cSD8ww3lGUyWZpJIa63tdWJb20FYHKNEqtrlYoamHXi5ve5UU5lmW1n-7WKeA3HsCPfSogfGyJ5AAzxj4h2drAF_r6vqdcnISw57n3tnOCv_et50orLr176l4cvEoXqAbg6ODkRjtj4dP0U3WSCph-RbarGdn9hm6pr_Xk_nseRR1jL5ctoj8AoXQj9c
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mouse+and+human+antibodies+bind+HLA-E-leader+peptide+complexes+and+enhance+NK+cell+cytotoxicity&rft.jtitle=Communications+biology&rft.au=Li%2C+Dapeng&rft.au=Brackenridge%2C+Simon&rft.au=Walters%2C+Lucy+C.&rft.au=Swanson%2C+Olivia&rft.date=2022-03-28&rft.issn=2399-3642&rft.eissn=2399-3642&rft.volume=5&rft.issue=1&rft_id=info:doi/10.1038%2Fs42003-022-03183-5&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_s42003_022_03183_5
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2399-3642&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2399-3642&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2399-3642&client=summon